Talk:Todd:Catalytic, Asymmetric Pictet-Spengler Reaction: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
(Added comment in Sandbox)
 
(222 intermediate revisions by 7 users not shown)
Line 4: Line 4:


1. Papers below need looking at - whether to include or not<br>
1. Papers below need looking at - whether to include or not<br>
2. More papers should be found, either by doing citation searches on papers already included, or doing new searches.<br>
2. More papers might be relevant. Can do citation searches on papers already included, or new searches.<br>
3. Papers that are already in the review, and have been summarized, need checking (see Quality Control, below)<br>
3. Papers that are already in the review, and have been summarized, need checking (see Quality Control, below for what's needed)<br>
4. Easy thing - papers below need DOI links inserting so they may be found easily, formatted like this example: [http://dx.doi.org/10.1002/anie.201008071 Stoeckigt and Waldmann Angew 2011]<br>
4. Insert DOI link for any paper lacking them on this page, formatted like this: [http://dx.doi.org/10.1002/anie.201008071 Stoeckigt and Waldmann Angew 2011]<br>


Some specific things that currently need doing:<br>
Some specific things that currently need doing:<br>
1. General description of what the PS reaction is, with a scheme of the very first example - essentially a description of the very first paper.<br>
1. Need examples of important bioactive molecules and commercial molecules, e.g. drugs, that can be made with the PS.<br>
2. Examples of important bioactive molecules that can be made with the PS need to be found.<br>
2. Intro needs polishing off.
3. The Lewis Acid section needs thought. Are there examples of catalytic Lewis Acids?<br>


Please don't use email if at all possible. Use this page or some other public forum. Remember if you want to contribute you are going to need an [http://openwetware.org/wiki/Join account on OWW] and one on [http://www.mendeley.com/groups/1170921/praziquantel-synthesis-via-pictet-spengler-reaction/ Mendeley] where we are collecting citations. We are currently (Jan21) working on a Dropbox solution to share papers and file between authors - to be resolved.<br>
Small things that are needed:<br>
1. Can anyone source a translation of the original Pictet-Spengler article? 10.1002/cber.19110440309. MHT - would be nice to see exactly how it is described there, yes. KAB - translation in progress!
 
Please don't use email if at all possible. Use this page or some other public forum. Remember if you want to contribute you are going to need an [http://openwetware.org/wiki/Join account on OWW] and one on [http://www.mendeley.com/groups/1170921/praziquantel-synthesis-via-pictet-spengler-reaction/ Mendeley] where we are collecting citations. There is a shared Dropbox folder for access to all Chemdraw files and PDFs - for access contact [https://plus.google.com/u/0/113014781212630252105/posts Murray]<br>


==General Comments, either on science or the review more broadly==
==General Comments, either on science or the review more broadly==


MHT - Jan19 - the page is quite long. We could consider splitting into sections if anyone is having a browser problem, but otherwise we keep as-is. Much more convenient having everything on one page.<br>
Suggestions can go directly here or on the main page in italics. Minor comments can go in the sandbox area below.<br>
 
1. '''Length''': the page is quite long, but easier to leave as-is than split the page.<br>
2. '''Molecule numbering''': will happen at the end of the writing process.<br>
3. '''Yield/ee terminology''': Very high = 90+, high = 80+, good = 70+, moderate = 60+.<br>
4. '''Plagiarism''': make sure that no phrases are ever lifted directly from any paper.<br>
5. '''Inserting schemes''': On any page, on the left panel, under tool-box, you will need to select "Upload File." From there you upload the .png file from your computer. Copy the name of the file when it's uploaded (If you're unsure of the file naming convention, click anyone of the scheme .png's and it'll have the details there). Be careful if your file has the same name as an existing one - consider using a different name. Once you've uploaded the file you just need to edit the page where you'd like it to appear. Find the code for some previously uploaded scheme (doesn't matter which), copy and paste it to where you want to put your scheme, and just replace the name of the file you copied, with the name of your file that you just uploaded. Be careful to include .png and be careful of the spacing, there shouldn't be any within the file name. From there, just replace the title of the previous scheme with the details of your scheme. It's important that you only change the words and none of the punctuation that you may see in the code, e.g. "" or |. Just to check if it's alright, you may want to preview before you post. As always with wikis - use other peoples' examples.<br>


MHT - Jan 21 - In the 2007 Hiemstra work, why does the sulfenyl help? Paper says should stabilize intermediate iminium ion and favour cyclization over competitive enamine formation) Paper gives: The use of N-sulfenyl substituents as protecting groups is known in peptide synthesis; see a) L. Zervas, D. Borovas, E. Gazis, J. Am. Chem. Soc. 1963, 85, 3660 – 3666 ; for reviews on sulfenamide chemistry, see b) F. A. Davis, U. K. Nadir, Org. Prep. Proced. Int. 1979, 11, 33–51; c)L. Craine, M. Raban, Chem. Rev. 1989, 89, 689 – 712 ; d) I. V. Koval, Russ. Chem. Rev. 1996, 65, 452 – 473. <br>
MHT - Jan 21 - In the 2007 Hiemstra work, why does the sulfenyl help? Paper says should stabilize intermediate iminium ion and favour cyclization over competitive enamine formation) Paper gives: The use of N-sulfenyl substituents as protecting groups is known in peptide synthesis; see a) L. Zervas, D. Borovas, E. Gazis, J. Am. Chem. Soc. 1963, 85, 3660 – 3666 ; for reviews on sulfenamide chemistry, see b) F. A. Davis, U. K. Nadir, Org. Prep. Proced. Int. 1979, 11, 33–51; c)L. Craine, M. Raban, Chem. Rev. 1989, 89, 689 – 712 ; d) I. V. Koval, Russ. Chem. Rev. 1996, 65, 452 – 473. <br>


MHT - Jan21 - Do we have a significant section on enzyme examples, or do we refer to the 2011 Waldmann review, which appears to cover this well? I would favour a brief description, with the value being clues we learn about the mechanism of catalysis, and whether we can apply those lessons to small molecule catalysis.
MHT - Jan 22 - This paper is listed in the references, but has it been read and digested, to extract a) relevant info about the PS, but mainly b) mechanistic ideas of relevance? If not, leave the ref where it is, but add note in mech section about the need to include it there. Small-Molecule H-Bond Donors in Asymmetric Catalysis, A. G. Doyle and E. N. Jacobsen, ''Chem. Rev.'' '''2007''', ''107'', 5713-5743.


MHT - Jan 22 - This paper is listed in the references, but has it been read and digested, to extract a) relevant info about the PS, but mainly b) mechanistic ideas of relevance? If not, leave the ref where it is, but add note in mech section about the need to include it there. Small-Molecule H-Bond Donors in Asymmetric Catalysis, A. G. Doyle and E. N. Jacobsen, ''Chem. Rev.'' '''2007''', ''107'', 5713-5743.
'''Appendices'''


MHT - Jan 22 - Be aware we are going, at some point, to need to number molecules in the schemes, so we can refer to them directly in the text. This needs to be left till the end, to avoid having to renumber things, but I mention this in case you're finding ''not'' using numbers to refer to specific compounds cumbersome.
:'''Appendix 1'''
ILT - June 25 2016 - As it is difficult to construct very large schemes in Chemdraw I drew the substrate analogs for Appendix 1 in Chemdraw and then arranged them in Adobe Illustrator. The .pdf and .png files of the finished scheme are in Dropbox → Pictet-Spengler Review → Schemes → Appendices. I have also put all the relevant Chemdraw files in this folder as well.


==Sandbox area for minor/temporary comments==
==Sandbox area for minor/temporary comments==


This is the place to chat. Use initials for your comments/questions. Inactive chats/resolved things can be cut from here and pasted at the bottom of the page.
This is the place to chat. Use initials for your comments/questions. Inactive chats/resolved things can be cut from here and pasted at the bottom of the page.
AEW- Feb 06 2013 - rather than having a separate mechanistic section can we include this in the relevant sections, saves repetition and might be clearer for readers. e.g. if you want to know about BA catalysed P-S reaction, its all in one place.
AEW- Feb 06 2013 - in a similar point, should there be a separate Natural products chapter?
AEW - Feb 03 2013 - In all cases, a single yield and ee are shown for a representative substrate from a paper. Is it not more useful to present a range of results to give a more accurate flavour of the paper being reviewed?


KAB - Jan22 - Added two .cdx files to DropBox under "All BINAP-derived" and "All Organocatalysts", with all the summarised papers' catalysts. MHT - good idea.
KAB - Jan22 - Added two .cdx files to DropBox under "All BINAP-derived" and "All Organocatalysts", with all the summarised papers' catalysts. MHT - good idea.
Line 35: Line 50:
KAB - Jan22 - (not sure of relevancy) Found "Stereoselectivity of Superacid-Catalyzed Pictet−Spengler Cyclization Reactions." 2003 Ohwada OrgLett (added to DropBox). Proposes dicationic intermediate/transition state(?) mechanism for PS reaction of non-activated aromatics in the presence of catalytic (achiral) acid. MHT - sounds interesting, will check it out.
KAB - Jan22 - (not sure of relevancy) Found "Stereoselectivity of Superacid-Catalyzed Pictet−Spengler Cyclization Reactions." 2003 Ohwada OrgLett (added to DropBox). Proposes dicationic intermediate/transition state(?) mechanism for PS reaction of non-activated aromatics in the presence of catalytic (achiral) acid. MHT - sounds interesting, will check it out.


MHT - Jan 22 - Reworked Dixon 2010 into one scheme. KAB please check and comment. ''KAB: Neater. So forego the "best" result, in terms of ee and yield and instead incorporate the mech into the scheme?''
KAB - Feb11 - Significant discussion of PS mechanism and acid-base effects on non-enzymatic aq solution PS reactions with enzyme cat. reactions, using kinetic isotope effects. RDS appears to be the same for both systems. Discusses pH dependence of enzyme for catalysis but not binding of substrate. Also, proposal of enzyme mechanism with key Glu309, where tryptamine is deprotonated, increasing its nucleophilicity for aldehyde attack. Not sure of how (or if) this is to be spread between mech vs enzyme section?
 
MAT - Feb11 - KAB, I'm trying to nail down more of the enzymatic "practical uses" in the Enzymatic Catalysis section, but I moved my comment about the OpSTS computation TS to your mechs section. I think, as Mat mentioned, that the catalysis section has to be for actual end-products, so I'll likely write up the NCS generation of benzoisoquinoline nps and O'Connor / Stockigt's work with fluorinated tryptamines for my section.
 
==Progress in 2016==
 
ILT – June 27 2016 – Since April, 2016 I have been working on the enzymatic catalysis section.  Using [http://www.cas.org/products/scifinder SciFinder] I looked through all the papers to date that have cited Waldmann 2011 ([http://dx.doi.org/10.1002/anie.201008071 10.1002/anie.201008071]). I have included all relevant papers except the the ones listed on the Talk page under 'Enzymatic section'. These are the key papers for the subsection of the the review 'Expanding our Knowledge of the Pictet-Spenglerase Family'. They are grouped by enzyme.
 
I have added several papers under 'What is Known of the Mechanisms of Existing Systems' which I have come across while working on the enzyme and thiourea sections of the review. Although some of these papers have already been included in the review, there are sections within them which discuss mechanistic details which have not yet been covered.
 
In the enzymatic catalysis section I made three new subsections: ''Substrate Specificity'', ''Rational Reengineering of Pictet-Spenglerases'' and ''Expanding our Knowledge of the Pictet-Spenglerase Family''. I also created an Appendices heading and uploaded Appendix 1 - a complete (I think) scheme collating all the Pictet-Spenglerase substrate specificity data to date. This data is summarised in Scheme: (Substrate specificity for Pictet-Spenglerases).
 
ILT – Apr 10 2016 – Over the past month I conducted a thorough search for thiourea organocatalyst papers that have not yet been included. I did not find any area of research that has not already been covered. During my search I kept an eye out for other new organocatalysts but did not find anything of interest. I used the following research method:
 
Using [http://www.cas.org/products/scifinder SciFinder] I searched for papers published between 2012 and March 2016 citing Jacobsen’s 2004 [http://dx.doi.org/10.1021/ja046259p Paper] (DOI: 10.1021/ja046259p) in which a chiral thiourea catalyst is used to promote an enantioselective Pictet-Spengler reaction for the first time. I searched for papers published since 2012 because I believe this is the last time someone focused on this section of the review.
 
I used the same method to look for more recent research by searching for papers citing Jacobsen’s latest [http://dx.doi.org/10.1021/ol202300t 2011 work] on thiourea-catalysed asymmetric Pictet-Spengler reactions (DOI: 10.1021/ol202300t).
 
I found several relevant reviews with brief sections devoted to elements covered in this review. I will mention these in a sentence or two towards the end of the introduction. In these reviews I did not find any thiourea research that has not already been included. As the most recent of these reviews was published in 2015, it supports my belief that there is no very obvious recent research that we have missed.
 
I now plan to turn my focus to the enzymatic catalysis section.
 
==Specific Things That Need Doing==
 
'''Introduction'''
* Need intro scheme containing structures for strychnine, morphine, vinblastine and reserpine and a scheme showing the synthesis of strictosidine from a PS reaction between tryptamine and secologanin. Combine with the existing structures of (-)-suaveoline and (-)-phalarine
* A number of small "needs" have been added to the intro section
 
'''Quality Control''
*Several "checks" still needed - essentially for accuracy of data and schemes, but stylistic points welcomed.


==Papers that are relevant and need to be included for the first time==
==Papers that are relevant and need to be included for the first time==
Line 41: Line 85:
''These papers are relevant and have not yet been included. They need a summary paragraph and possibly a scheme. Papers that are included need to have their citation data put in the right place in the review, and need to be added to the [http://www.mendeley.com/groups/1170921/praziquantel-synthesis-via-pictet-spengler-reaction/ Mendeley Page]. Papers that are not included should be listed in full in the "not-being used" section but do not need to be added to the Mendeley library.''
''These papers are relevant and have not yet been included. They need a summary paragraph and possibly a scheme. Papers that are included need to have their citation data put in the right place in the review, and need to be added to the [http://www.mendeley.com/groups/1170921/praziquantel-synthesis-via-pictet-spengler-reaction/ Mendeley Page]. Papers that are not included should be listed in full in the "not-being used" section but do not need to be added to the Mendeley library.''


None currently pending
* ''KAB: relevant. Early use of chiral phosphoric acids (binol and H8-binol) in enantioselective Morita-Baylis-Hillman reaction.'' N. T. McDougal, S. E. Schaus, J. Am. Chem. Soc. 2003, 125, 12094 (DOI: 10.1021/ja037705w) [http://dx.doi.org/10.1021/ja037705w Paper] MHT - that sounds very relevant - a year before Akiyama/Terada. Needs to be properly included? KAB Jan23 - Probably. It's a bit different to the rest. Acids were catalytic, but also required a "nucleophilic promotor." Not sure what that is, but it was present in less than stoich amounts as well. AEW - I'm not convinced that this paper is relevant for full inclusion. Should maybe be referenced but there are earlier examples of the use of chiral Bronsted acids...important to note that its not phosphoric acids as stated above but Binapthyl derived acids. Also, nothing strange about the ''nucleophilic promoter'' this is a requirement in M-B-H reactions - most frequently DABCO but can also be a phosphine (as in this case).
 
* ILT - June 27 2016 - Botta, 2016 [http://dx.doi.org/10.2174/1381612822666151231100247 10.2174/1381612822666151231100247] - Recent review of Pictet-Spengler reaction. Difficult to find paper so I put the pdf in the Dropbox 'PDFs' folder.


== Papers that have not yet been included, but have been referenced by others ==
== Papers that have not yet been included, but have been referenced by others ==
Line 49: Line 95:
===Introduction/Background to the PS Reaction===
===Introduction/Background to the PS Reaction===


These general reviews need to be checked, to ensure we have not missed anything, and as inspiration for thoughts on the reaction mechanism.
Early examples: probably rac/achiral
 
* [http://dx.doi.org/10.2174/157017910791163011 Current Organic Synthesis 2010] - We have this in Sydney, but access is non-trivial.
* [http://dx.doi.org/10.1002/anie.201008071 Stoeckigt and Waldmann Angew 2011]
* Pulka, K. Curr. Opin. Drug Discov. Devel. 2010, 13, 669–684 - referenced from Franz 2011


Early examples: probably rac/achiral
* Pictet, A.; Spengler, T. Ber. Dtsch. Chem. Ges. 1911, 44, 2030-2036. (DOI: 10.1002/cber.19110440309) [http://dx.doi.org/10.1002/cber.19110440309 Paper]
* Tatsui, G. J. Pharm. Soc. Jpn. 1928, 48, 92 (may be 453-459).
* Cox, E. D.; Cook, J. M. Chem. Rev. 1995, 95, 1797- 1842 (especially their tryptophan ester strategy) (DOI: 10.1021/cr00038a004) [http://dx.doi.org/10.1021/cr00038a004 Paper]
* Chrzanowska, M.; Rozwadowska, M. D. Chem. Rev. 2004, 104, 3341-3370. (DOI: 10.1021/cr030692k) [http://dx.doi.org/10.1021/cr030692k Paper]
* Nature: Naoi, M.; Maruyama, W.; Nagy, G. M. Neurotoxicology 2004, 25, 193- 204 (DOI: 10.1016/S0161-813X(03)00099-8) [http://dx.doi.org/10.1016/S0161-813X(03)00099-8 Paper]
* Nature: Naoi, M.; Maruyama, W.; Nagy, G. M. Neurotoxicology 2004, 25, 193- 204 (DOI: 10.1016/S0161-813X(03)00099-8) [http://dx.doi.org/10.1016/S0161-813X(03)00099-8 Paper]


Some good medicinal chemistry examples of isatin-derived compounds in Franz 2011.<br>
Some good medicinal chemistry examples of isatin-derived compounds in Franz 2011 and bencivennia 2011.<br>


Check for the importance of the structural motifs constructed with the reaction:
Check for the importance of the structural motifs constructed with the reaction:
Line 68: Line 105:
* Bentley, K. W. Nat. Prod. Rep. 2004, 21, 395-424 and references therein
* Bentley, K. W. Nat. Prod. Rep. 2004, 21, 395-424 and references therein
* W. Jiang, J. Guan, M. J. Macielag, S. Zhang, Y. Qiu, P. Kraft, S. (DOI: 10.1021/jm025545d) [http://dx.doi.org/10.1021/jm025545d Paper]
* W. Jiang, J. Guan, M. J. Macielag, S. Zhang, Y. Qiu, P. Kraft, S. (DOI: 10.1021/jm025545d) [http://dx.doi.org/10.1021/jm025545d Paper]
Example chiral auxiliary approach: H. Waldmann, G. Schmidt, H. Henke, and M. Burkard, Angew. Chem. Int. Ed Engl., 1995, 34, 2401. as an example of an "easily removable" chiral aux not being too different from a chiral reagent? Referenced by Nakagawa.


Also possibly:
Also possibly:
Line 78: Line 117:
* Ma, J.; Yin, W.; Zhou, H.; Cook, J. M. Org. Lett. 2007, 9, 3491–3494 (DOI: 10.1021/ol071220l) [http://dx.doi.org/10.1021/ol071220l Paper]
* Ma, J.; Yin, W.; Zhou, H.; Cook, J. M. Org. Lett. 2007, 9, 3491–3494 (DOI: 10.1021/ol071220l) [http://dx.doi.org/10.1021/ol071220l Paper]
* Herraiz, T. J. Chromatogr. A 2000, 881, 483–499 (DOI: 10.1016/S0021-9673(99)01313-8) [http://dx.doi.org/10.1016/S0021-9673(99)01313-8 Paper]
* Herraiz, T. J. Chromatogr. A 2000, 881, 483–499 (DOI: 10.1016/S0021-9673(99)01313-8) [http://dx.doi.org/10.1016/S0021-9673(99)01313-8 Paper]
* Herraiz, T.; Galisteo, J.; Chamorro, C. J. Agric. Food Chem. 2003, 51, 2168–2173. (DOI: 10.1021/jf0210066) [http://dx.doi.org/10.1021/jf0210066 Paper]
* Herraiz, T.; Galisteo, J.; Chamorro, C. J. Agric. Food Chem. 2003, 51, 2168–2173. (DOI: 10.1021/jf0210066) [http://dx.doi.org/10.1021/jf0210066 Paper] Could cite - carbolines show antioxidant activity.


Diastereoselective examples:
Diastereoselective examples:
Line 91: Line 130:
* Czarnocki, Z.; Suh, D.; MacLean, D. B.; Hultin, P. G.; Szarek, W. A. Can. J. Chem. 1992, 70, 1555-1561. (DOI: 10.1139/v92-191) [http://dx.doi.org/10.1139/v92-191 Paper]
* Czarnocki, Z.; Suh, D.; MacLean, D. B.; Hultin, P. G.; Szarek, W. A. Can. J. Chem. 1992, 70, 1555-1561. (DOI: 10.1139/v92-191) [http://dx.doi.org/10.1139/v92-191 Paper]
* Czarnocki, Z.; Mieckzkowsi, J. B.; Kiegiel, J.; Arazn ́y, Z. Tetrahyedron: Asymmetry 1995, 6, 2899-2902. (DOI: 10.1016/0957-4166(95)00380-0) [http://dx.doi.org/10.1016/0957-4166(95)00380-0 Paper]
* Czarnocki, Z.; Mieckzkowsi, J. B.; Kiegiel, J.; Arazn ́y, Z. Tetrahyedron: Asymmetry 1995, 6, 2899-2902. (DOI: 10.1016/0957-4166(95)00380-0) [http://dx.doi.org/10.1016/0957-4166(95)00380-0 Paper]
* Tsuji, R.; Nakagawa, M.; Nishida, A. Tetrahedron: Asymmetry 2003, 14, 177- 180. (DOI: 10.1016/S0957-4166(02)00793-0) [http://dx.doi.org/10.1016/S0957-4166(02)00793-0 Paper]
 
 
Papers relating to indole chemistry in asymmetric catalysis, cited by Bencivennia 2011:
* M. Bandini, A. Eicholtzer, Angew. Chem. Int. Ed. 2009, 48, 9608–9644
* G. Bartoli, G. Bencivenni, R. Dalpozzo, Chem. Soc. Rev. 2010, 39, 4449 – 4465
* T. B. Poulsen, K. A. Jørgensen, Chem. Rev. 2008, 108, 2903 – 2915
* E. MarquØs-López, R. P. Herrera, M. Christmann, Nat. Prod. Rep. 2010, 27, 1138 – 1167
 
Diastereoselective cited by Leighton:
C. Bohlmann, R. Bohlmann, E. G. Rivera, C. Vogel, M. D. Manandhar, E. Winterfeldt, Liebigs Ann. Chem. 1985, 1752
R. Amann, D. Spitzner, Angew. Chem. 1991, 103, 1373; Angew. Chem. Int. Ed. Engl. 1991, 30, 1320
D. L. Comins, M. M. Badawi, Tetrahedron Lett. 1991, 32, 2995
H. Wald- mann, G. Schmidt, M. Jansen, J. Geb, Tetrahedron Lett. 1993, 34, 5867
H. Waldmann, G. Schmidt, M. Jansen, J. Geb, Tetrahedron 1994, 50, 11865
H. Waldmann, G. Schmidt, H. Henke, M. Burkard, Angew. Chem. 1995, 107, 2608; Angew. Chem. Int. Ed. Engl. 1995, 34, 2402
T. Soe, T. Kawate, N. Fukui, T. Hino, M. Nakagawa, Heterocycles 1996, 42, 347
T. Kawate, M. Yamanaka, M. Nakagawa, Heterocycles 1999, 50, 1033


===Diastereoelective Reactions===
===Diastereoelective Reactions===
First examples?
* Ungemach, F.; Soerens, D.; Weber, R.; DiPierro, M.; Campos ;Mokry, P.; Cook, J. M.; Silverton, J. V. J. Am. Chem. Soc. 1980,102,6976.


Diastereoselective (note: must be catalytic for full inclusion - may be no examples):
Diastereoselective (note: must be catalytic for full inclusion - may be no examples):
Line 99: Line 157:
* Czarnocki, Z.; Suh, D.; MacLean, D. B.; Hultin, P. G.; Szarek, W. A. Can. J. Chem. 1992, 70, 1555-1561. (DOI: 10.1139/v92-191) [http://dx.doi.org/10.1139/v92-191 Paper]
* Czarnocki, Z.; Suh, D.; MacLean, D. B.; Hultin, P. G.; Szarek, W. A. Can. J. Chem. 1992, 70, 1555-1561. (DOI: 10.1139/v92-191) [http://dx.doi.org/10.1139/v92-191 Paper]
* Czarnocki, Z.; Mieckzkowsi, J. B.; Kiegiel, J.; Arazn ́y, Z. Tetrahyedron: Asymmetry 1995, 6, 2899-2902. (DOI: 10.1016/0957-4166(95)00380-0) [http://dx.doi.org/10.1016/0957-4166(95)00380-0 Paper]
* Czarnocki, Z.; Mieckzkowsi, J. B.; Kiegiel, J.; Arazn ́y, Z. Tetrahyedron: Asymmetry 1995, 6, 2899-2902. (DOI: 10.1016/0957-4166(95)00380-0) [http://dx.doi.org/10.1016/0957-4166(95)00380-0 Paper]
* Tsuji, R.; Nakagawa, M.; Nishida, A. Tetrahedron: Asymmetry 2003, 14, 177- 180. (DOI: 10.1016/S0957-4166(02)00793-0) [http://dx.doi.org/10.1016/S0957-4166(02)00793-0 Paper]


===Lewis Acids===
===Lewis Acids===


Currently have Nakagawa, which is not catalytic. Don't need more examples of reagent-controlled enantioselective PS - only include more Lewis acid examples if very noteworthy or catalytic.
This section is done
 
Check:
* Hino, T.; Nakagawa, M. Heterocycles 1998, 49, 499-531.
* Leighton [http://dx.doi.org/10.1002/anie.200806110 Angew 2009]


===Bronsted Acid Section===
===Bronsted Acid Section===
Line 114: Line 167:


* ''KAB: Not relevant. Not chiral acid, use of chiral aux. in Diels-Alder.'' C. Palomo, M. Oiarbide, J. M. Garcia, A. Gonzalez, A. Lecumberri, A. Linden, J. Am. Chem. Soc. 2002, 124, 10288 (DOI: 10.1021/ja025906e) [http://dx.doi.org/10.1021/ja025906e Paper]
* ''KAB: Not relevant. Not chiral acid, use of chiral aux. in Diels-Alder.'' C. Palomo, M. Oiarbide, J. M. Garcia, A. Gonzalez, A. Lecumberri, A. Linden, J. Am. Chem. Soc. 2002, 124, 10288 (DOI: 10.1021/ja025906e) [http://dx.doi.org/10.1021/ja025906e Paper]
* ''KAB: relevant. Early use of chiral phosphoric acids (binol and H8-binol) in enantioselective Morita-Baylis-Hillman reaction.'' N. T. McDougal, S. E. Schaus, J. Am. Chem. Soc. 2003, 125, 12094 (DOI: 10.1021/ja037705w) [http://dx.doi.org/10.1021/ja037705w Paper] MHT - that sounds very relevant - a year before Akiyama/Terada. Needs to be properly included?
* ''KAB: relevant. Early use of chiral phosphoric acids (binol and H8-binol) in enantioselective Morita-Baylis-Hillman reaction.'' N. T. McDougal, S. E. Schaus, J. Am. Chem. Soc. 2003, 125, 12094 (DOI: 10.1021/ja037705w) [http://dx.doi.org/10.1021/ja037705w Paper] MHT - that sounds very relevant - a year before Akiyama/Terada. Needs to be properly included? KAB Jan23 - Probably. It's a bit different to the rest. Acids were catalytic, but also required a "nucleophilic promotor." Not sure what that is, but it was present in less than stoich amounts as well.
* ''KAB: not quite relevant. Uses H-bond activation via chiral TADDOL, in highly enantioselective Hetero-Diels-Alder.''  Y. Huang, A. K. Unni, A. N. Thadani, V. H. Rawal, Nature 2003, 424, 146. MHT - sure, but why is this paper in Nature? What is it showing that is so important, and does this need to be mentioned in the mech section?
* ''KAB: not quite relevant. Uses H-bond activation via chiral TADDOL, in highly enantioselective Hetero-Diels-Alder.''  Y. Huang, A. K. Unni, A. N. Thadani, V. H. Rawal, Nature 2003, 424, 146. MHT - sure, but why is this paper in Nature? What is it showing that is so important, and does this need to be mentioned in the mech section?


Akiyama (2004) also mentions these "metal salt" versions:
Akiyama (2004) also mentions these "metal salt" versions:
*J. Inanaga, Y. Sugimoto, T. Hanamoto, New J. Chem. 1995, 19, 707
*J. Inanaga, Y. Sugimoto, T. Hanamoto, New J. Chem. 1995, 19, 707 ''(KAB: Can't access on usyd subscription)''
*H. Furuno, T. Hanamoto, Y. Sugimoto, J. Inanaga, Org. Lett. 2000, 2, 49 (DOI: 10.1021/ol991189q) [http://dx.doi.org/10.1021/ol991189q Paper]
* ''KAB: Hetero-DA asymmetric amplification by chiral Yb complexes.'' H. Furuno, T. Hanamoto, Y. Sugimoto, J. Inanaga, Org. Lett. 2000, 2, 49 (DOI: 10.1021/ol991189q) [http://dx.doi.org/10.1021/ol991189q Paper]


Previous Bronsted acid example from Terada
Previous Bronsted acid example from Terada
* Schreiner, P. R. Chem. Soc. ReV. 2003, 32, 289.
* ''KAB: Not relevent. Chiral TADDOL used in hetero-DA reaction'' - Huang, Y.; Unni, A. K.; Thadani, A. N.; Rawal, V. H. Nature 2003, 424, 146.
* Huang, Y.; Unni, A. K.; Thadani, A. N.; Rawal, V. H. Nature 2003, 424, 146.
* ''KAB: See above'' - McDougal, N. T.; Schaus, S. E. J. Am. Chem. Soc. 2003,125, 12094.
* McDougal, N. T.; Schaus, S. E. J. Am. Chem. Soc. 2003,125, 12094.


Example of chiral charged Brønsted acid catalyst:
Example of chiral charged Brønsted acid catalyst:
Line 157: Line 209:
* List, Top. Curr. Chem. 2010, 291, 395-456
* List, Top. Curr. Chem. 2010, 291, 395-456
* Rueping Angewandte 2011, 50, 6706-6720
* Rueping Angewandte 2011, 50, 6706-6720
* S.-L. You, Q. Cai, M. Zeng, Chem. Soc. Rev. 2009, 38, 2190 – 2201
* A. Zamfir, S. Schenker, M. Freund, S. B. Tsogoeva, Org. Biomol. Chem. 2010, 8, 5262 – 5276 (DOI: 10.1039/c0ob00209g)
Bronsted Acids: ''N''-triflyl phosphoramide [http://dx.doi.org/10.1021/ja062508t Yamamoto '''2006'''], ''N''-triflyl phosphoramide [10.1002/anie.200802139 Rueping '''2008'''] , ? [http://dx.doi.org/10.1055/s-0029-1218539 Rueping '''2010''']<br>
Diastereoselective polycyclization involving unactivated Ph using SnCl<sub>4</sub> [http://dx.doi.org/10.1021/ol062378t Yamamoto '''2006'''] - suggestion [http://www.thesynapticleap.org/node/205#comment-643 here] to use this enantioselectively.<br>
Link from PS page - MNR
[http://dx.doi.org/10.1055/s-0029-1217324 Nakamura '''2009'''] - but Aza-Friedel-Crafts Alkylation of Pyrroles<br>
Possible alternative thiophosphoramide: [http://dx.doi.org/10.1021/ja8041542 Yamamoto '''2008''']
* Asymmetric Bronsted Acid Catalyzed Nucleophilic Addition to in situ Generated Chiral N-Acyliminium Ions, Rueping, M.; Nachtsheim, B. J. Synlett 2010, 1, 119. (DOI: 10.1055/s-0029-1218539) - KAB: Probably needs to go in the B acid section.


===Organocatalysis Section===
===Organocatalysis Section===


Not looked at to see which section these go in:
This section is done.
* Rueping, M.; Nachtsheim, B. J. Synlett 2010, 1, 119.
* Peterson, E. A.; Jacobsen, E. N. Angew. Chem., Int. Ed. 2009, 48, 6328.
* Raheem, I. T.; Thiara, P. S.; Jacobsen, E. N. Org. Lett. 2008, 10, 1577
* Sun, F.-L.; Zheng, X.-J.; Gu, Q.; He, Q.-L.; You, S.-L. Eur. J. Org. Chem. 2010, 47


===Mechanism section===
===Mechanism section===
Line 178: Line 238:
* Rueping, M.; Koenigs, R. M.; Atodiresei, I. Chem. Eur. J. 2010, 16, 9350–9365.
* Rueping, M.; Koenigs, R. M.; Atodiresei, I. Chem. Eur. J. 2010, 16, 9350–9365.


===Other Relevant Systems not yet applied to the PS===
The general reviews need to be checked, to ensure we have not missed anything, and as inspiration for thoughts on the reaction mechanism. e.g. Govindra Org Reactions review we've already cited.
 
''Check these papers for possible suitability for the PS, and check that they have not been so-used. The aim is to say in the review which catalysts show promise but are unexplored.''
 
Strong Bronsted acids not yet applied to PS:<br>
 
* Chiral N-triflyl phosphoramide [http://dx.doi.org/10.1021/ja062508t Yamamoto 2006]
 
Check:
* C. H. Cheon, H. Yamamoto, J. Am. Chem. Soc. 2008, 130, 9246–9247 (DOI: 10.1021/ja8041542) [http://dx.doi.org/10.1021/ja8041542 Paper]<br>
* C. H. Cheon, H. Yamamoto, Org. Lett. 2010, 12, 2476–2479 (DOI: 10.1021/ol100233t) [http://dx.doi.org/10.1021/ol100233t Paper]<br>
* M. Rueping, W. Ieawsuwan, A. P. Antonchick, B. J. Nacht- sheim, Angew. Chem. Int. Ed. 2007, 46, 2097–2100<br>
* P. Jiao, D. Nakashima, H. Yamamoto, Angew. Chem. Int. Ed. 2008, 47, 2411–2413.<br>
* H. Xu, S. J. Zuend, M. G. Woll, Y. Tao, E. N. Jacobsen, Science 2010, 327, 986–990 (mixture).<br>
* M. Treskow, J. Neudörfl, R. Giernoth, Eur. J. Org. Chem. 2009, 3693–3697.<br>
* P. García-García, F. Lay, P. García-García, C. Rabalakos, B. List, Angew. Chem. Int. Ed. 2009, 48, 4363–4366.<br>
 
TADDOL ligands:
* [http://dx.doi.org/10.1002/adsc.200505167 Akiyama 2005]
* (TADDOL activator) [http://dx.doi.org/10.1038/424146a Rawal 2003]
 
Enzymatic examples:<br>
* Norcoclaurine synthase [http://dx.doi.org/10.1021/bi700752n Tanner 2007]<br>
* Strictosidine Synthase [http://dx.doi.org/10.1021/ja077190z Stoeckigt 2008]<br>
* Deacetylipecoside Synthase - need ref if this is a relevant enzyme
 
==Simple items to do==
 
* MHT - Jan21 - Need people to go through all the references on this page and insert a DOI link for ease of access.<br>
* KAB - Jan22 - Need to annotate Dixon 2010 Cyclisation Cascade with keq's and kminor and kmajor - but MHT has altered this scheme, and I don't think the k's add anything.
 
==Quality Control==
 
''All papers included in the main text of the review will have been summarised by one person. The summary (text and scheme) need to be checked by at least one other person -'' '''that means going back to the primary literature source'''. ''This section contains a list of who has done what.''


Arrange list in approximate order of appearance in review.
===Enzymatic Section===


* Nakagawa 1998 (10.1021/jo980810h) - written by MNR, not yet checked.<br>
Abe, 2015 ([http://dx.doi.org/10.1016/j.chembiol.2015.06.006 10.1016/j.chembiol.2015.06.006]) - Already included, however did not cover stereoselectivity of McbB.
* Akiyama (10.1002/anie.200353240) - written by MHT, not yet checked.<br>
* Terada (10.1021/ja0491533) - written by MHT, not yet checked.<br>
* List 2006 (10.1021/ja057444l) - written by MHT, not yet checked.<br>
* Hiemstra 2007 (10.1002/anie.200701808) - written by KAB, checked by MNR & MHT.<br>
* Hiemstra 2008 (10.1021/jo8010478) - written by KAB, checked by MNR & MHT.<br>
* Hiemstra 2009 (10.1021/ol900888e) - written by MHT, not yet checked. <br>
* Hiemstra 2011 (10.1021/jo201657n) - written by MHT, not yet checked. <br>
* Dixon 2009 (10.1021/ja9024885) - written by MHT, not yet checked. <br>
* Dixon 2010 (10.1021/ol101651t) - written by KAB, checked and rewritten by MHT - needs further check.<br>
* Franz 2011 (10.1016/j.tetlet.2011.08.071) - written by MNR, significantly re-worked by MHT - needs further check.<br>
* Jacobsen 2004 - written by MNR, not yet checked.<br>
* Jacobsen 2007 - written by MNR, not yet checked.<br>
* Jacobsen 2007 review - written by MNR, not yet checked.<br>
* Jacobsen 2008 - written by MNR, not yet checked.<br>
* Jacobsen 2009 - written by MNR, not yet checked.<br>
* Jacobsen 2011 - written by MNR, not yet checked.<br>


== Resolved ==
Papers that may need to be included under '''Expanding our Knowledge of the Pictet-Spenglerase Family''' subsection under Enzymatic Catalysis:


* KAB - Jan21 - The scheme for 2009 Hiemstra with the H8-BINOL phosphoric acid in the box, doesn't have the H8-BINOL phosphoric acid in the box. Still has the BINOL. ''(KAB: fixed in the chemdraw file and re-uploaded the png, but it is yet show the change in the review.)'' - '''KAB, done.'''
:'''Monoamine Oxidase (MAO-N)''''
:* Turner, 2013 ''ACS Catal.'' ([http://dx.doi.org/10.1021/cs400724g 10.1021/cs400724g])


--
:'''Nonribosomal polypeptide synthetase, SfmC'''
''1. KAB attempt to understand 2000 Koomen OrgLett''  
:* Oikawa, 2010 ([http://dx.doi.org/10.1038/nchembio.365 10.1038/nchembio.365])
:* Oikawa, 2012 ([http://dx.doi.org/10.1016/j.cbpa.2012.02.021 10.1016/j.cbpa.2012.02.021])
:* Oikawa, 2012(2), Book chapter ([http://dx.doi.org/10.1016/B978-0-12-394291-3.00026-5 10.1016/B978-0-12-394291-3.00026-5])


The figure for Table 1 gives diasteromeric ratios. Where are the diastereomers? I only the possibility for enantiomers in the product. Where's the other stereogenic centre?
:'''(''R'')-Salsolinol synthase in human and rat brains'''
:* Naoi, 1996 ([http://dx.doi.org/10.1016/0304-3940(96)12807-X 10.1016/0304-3940(96)12807-X])
:* Naoi, 2004 ([http://dx.doi.org/10.1016/S0161-813X(03)00099-8 10.1016/S0161-813X(03)00099-8])
:* Deng, 2011 ([http://dx.doi.org/10.2478/s11756-011-0134-y 10.2478/s11756-011-0134-y])
:* Deng, 2013 ([http://dx.doi.org/10.1134/S1819712413030045 10.1134/S1819712413030045])
:* Deng, 2014 ([http://dx.doi.org/10.3892/ijmm.2013.1604 10.3892/ijmm.2013.1604])


They also mentioned "hydrolysis of the starting material" numerous times.  I'm assuming they mean hydrolysis of the N-S bond (there doesn't seem any other reasonable place for hydrolysis of the SM to occur), but I just wanted to check.
:'''Human morphine biosynthesis'''
'''This comment resolved since this paper no longer included in the review.'''
:* Zenk, 2005 ([http://dx.doi.org/10.1073
--

Latest revision as of 18:15, 26 June 2016

Use this page for discussion. Preface questions/comments with initials. Reply to questions but don't delete the question. If things are resolved, move them to the "resolved" section at the bottom of the page.

General Things that Need Doing

1. Papers below need looking at - whether to include or not
2. More papers might be relevant. Can do citation searches on papers already included, or new searches.
3. Papers that are already in the review, and have been summarized, need checking (see Quality Control, below for what's needed)
4. Insert DOI link for any paper lacking them on this page, formatted like this: Stoeckigt and Waldmann Angew 2011

Some specific things that currently need doing:
1. Need examples of important bioactive molecules and commercial molecules, e.g. drugs, that can be made with the PS.
2. Intro needs polishing off.

Small things that are needed:
1. Can anyone source a translation of the original Pictet-Spengler article? 10.1002/cber.19110440309. MHT - would be nice to see exactly how it is described there, yes. KAB - translation in progress!

Please don't use email if at all possible. Use this page or some other public forum. Remember if you want to contribute you are going to need an account on OWW and one on Mendeley where we are collecting citations. There is a shared Dropbox folder for access to all Chemdraw files and PDFs - for access contact Murray

General Comments, either on science or the review more broadly

Suggestions can go directly here or on the main page in italics. Minor comments can go in the sandbox area below.

1. Length: the page is quite long, but easier to leave as-is than split the page.
2. Molecule numbering: will happen at the end of the writing process.
3. Yield/ee terminology: Very high = 90+, high = 80+, good = 70+, moderate = 60+.
4. Plagiarism: make sure that no phrases are ever lifted directly from any paper.
5. Inserting schemes: On any page, on the left panel, under tool-box, you will need to select "Upload File." From there you upload the .png file from your computer. Copy the name of the file when it's uploaded (If you're unsure of the file naming convention, click anyone of the scheme .png's and it'll have the details there). Be careful if your file has the same name as an existing one - consider using a different name. Once you've uploaded the file you just need to edit the page where you'd like it to appear. Find the code for some previously uploaded scheme (doesn't matter which), copy and paste it to where you want to put your scheme, and just replace the name of the file you copied, with the name of your file that you just uploaded. Be careful to include .png and be careful of the spacing, there shouldn't be any within the file name. From there, just replace the title of the previous scheme with the details of your scheme. It's important that you only change the words and none of the punctuation that you may see in the code, e.g. "" or |. Just to check if it's alright, you may want to preview before you post. As always with wikis - use other peoples' examples.

MHT - Jan 21 - In the 2007 Hiemstra work, why does the sulfenyl help? Paper says should stabilize intermediate iminium ion and favour cyclization over competitive enamine formation) Paper gives: The use of N-sulfenyl substituents as protecting groups is known in peptide synthesis; see a) L. Zervas, D. Borovas, E. Gazis, J. Am. Chem. Soc. 1963, 85, 3660 – 3666 ; for reviews on sulfenamide chemistry, see b) F. A. Davis, U. K. Nadir, Org. Prep. Proced. Int. 1979, 11, 33–51; c)L. Craine, M. Raban, Chem. Rev. 1989, 89, 689 – 712 ; d) I. V. Koval, Russ. Chem. Rev. 1996, 65, 452 – 473.

MHT - Jan 22 - This paper is listed in the references, but has it been read and digested, to extract a) relevant info about the PS, but mainly b) mechanistic ideas of relevance? If not, leave the ref where it is, but add note in mech section about the need to include it there. Small-Molecule H-Bond Donors in Asymmetric Catalysis, A. G. Doyle and E. N. Jacobsen, Chem. Rev. 2007, 107, 5713-5743.

Appendices

Appendix 1

ILT - June 25 2016 - As it is difficult to construct very large schemes in Chemdraw I drew the substrate analogs for Appendix 1 in Chemdraw and then arranged them in Adobe Illustrator. The .pdf and .png files of the finished scheme are in Dropbox → Pictet-Spengler Review → Schemes → Appendices. I have also put all the relevant Chemdraw files in this folder as well.

Sandbox area for minor/temporary comments

This is the place to chat. Use initials for your comments/questions. Inactive chats/resolved things can be cut from here and pasted at the bottom of the page.

AEW- Feb 06 2013 - rather than having a separate mechanistic section can we include this in the relevant sections, saves repetition and might be clearer for readers. e.g. if you want to know about BA catalysed P-S reaction, its all in one place.

AEW- Feb 06 2013 - in a similar point, should there be a separate Natural products chapter?

AEW - Feb 03 2013 - In all cases, a single yield and ee are shown for a representative substrate from a paper. Is it not more useful to present a range of results to give a more accurate flavour of the paper being reviewed?

KAB - Jan22 - Added two .cdx files to DropBox under "All BINAP-derived" and "All Organocatalysts", with all the summarised papers' catalysts. MHT - good idea.

KAB - Jan22 - (not sure of relevancy) Found "Stereoselectivity of Superacid-Catalyzed Pictet−Spengler Cyclization Reactions." 2003 Ohwada OrgLett (added to DropBox). Proposes dicationic intermediate/transition state(?) mechanism for PS reaction of non-activated aromatics in the presence of catalytic (achiral) acid. MHT - sounds interesting, will check it out.

KAB - Feb11 - Significant discussion of PS mechanism and acid-base effects on non-enzymatic aq solution PS reactions with enzyme cat. reactions, using kinetic isotope effects. RDS appears to be the same for both systems. Discusses pH dependence of enzyme for catalysis but not binding of substrate. Also, proposal of enzyme mechanism with key Glu309, where tryptamine is deprotonated, increasing its nucleophilicity for aldehyde attack. Not sure of how (or if) this is to be spread between mech vs enzyme section?

MAT - Feb11 - KAB, I'm trying to nail down more of the enzymatic "practical uses" in the Enzymatic Catalysis section, but I moved my comment about the OpSTS computation TS to your mechs section. I think, as Mat mentioned, that the catalysis section has to be for actual end-products, so I'll likely write up the NCS generation of benzoisoquinoline nps and O'Connor / Stockigt's work with fluorinated tryptamines for my section.

Progress in 2016

ILT – June 27 2016 – Since April, 2016 I have been working on the enzymatic catalysis section. Using SciFinder I looked through all the papers to date that have cited Waldmann 2011 (10.1002/anie.201008071). I have included all relevant papers except the the ones listed on the Talk page under 'Enzymatic section'. These are the key papers for the subsection of the the review 'Expanding our Knowledge of the Pictet-Spenglerase Family'. They are grouped by enzyme.

I have added several papers under 'What is Known of the Mechanisms of Existing Systems' which I have come across while working on the enzyme and thiourea sections of the review. Although some of these papers have already been included in the review, there are sections within them which discuss mechanistic details which have not yet been covered.

In the enzymatic catalysis section I made three new subsections: Substrate Specificity, Rational Reengineering of Pictet-Spenglerases and Expanding our Knowledge of the Pictet-Spenglerase Family. I also created an Appendices heading and uploaded Appendix 1 - a complete (I think) scheme collating all the Pictet-Spenglerase substrate specificity data to date. This data is summarised in Scheme: (Substrate specificity for Pictet-Spenglerases).

ILT – Apr 10 2016 – Over the past month I conducted a thorough search for thiourea organocatalyst papers that have not yet been included. I did not find any area of research that has not already been covered. During my search I kept an eye out for other new organocatalysts but did not find anything of interest. I used the following research method:

Using SciFinder I searched for papers published between 2012 and March 2016 citing Jacobsen’s 2004 Paper (DOI: 10.1021/ja046259p) in which a chiral thiourea catalyst is used to promote an enantioselective Pictet-Spengler reaction for the first time. I searched for papers published since 2012 because I believe this is the last time someone focused on this section of the review.

I used the same method to look for more recent research by searching for papers citing Jacobsen’s latest 2011 work on thiourea-catalysed asymmetric Pictet-Spengler reactions (DOI: 10.1021/ol202300t).

I found several relevant reviews with brief sections devoted to elements covered in this review. I will mention these in a sentence or two towards the end of the introduction. In these reviews I did not find any thiourea research that has not already been included. As the most recent of these reviews was published in 2015, it supports my belief that there is no very obvious recent research that we have missed.

I now plan to turn my focus to the enzymatic catalysis section.

Specific Things That Need Doing

Introduction

  • Need intro scheme containing structures for strychnine, morphine, vinblastine and reserpine and a scheme showing the synthesis of strictosidine from a PS reaction between tryptamine and secologanin. Combine with the existing structures of (-)-suaveoline and (-)-phalarine
  • A number of small "needs" have been added to the intro section

'Quality Control

  • Several "checks" still needed - essentially for accuracy of data and schemes, but stylistic points welcomed.

Papers that are relevant and need to be included for the first time

These papers are relevant and have not yet been included. They need a summary paragraph and possibly a scheme. Papers that are included need to have their citation data put in the right place in the review, and need to be added to the Mendeley Page. Papers that are not included should be listed in full in the "not-being used" section but do not need to be added to the Mendeley library.

  • KAB: relevant. Early use of chiral phosphoric acids (binol and H8-binol) in enantioselective Morita-Baylis-Hillman reaction. N. T. McDougal, S. E. Schaus, J. Am. Chem. Soc. 2003, 125, 12094 (DOI: 10.1021/ja037705w) Paper MHT - that sounds very relevant - a year before Akiyama/Terada. Needs to be properly included? KAB Jan23 - Probably. It's a bit different to the rest. Acids were catalytic, but also required a "nucleophilic promotor." Not sure what that is, but it was present in less than stoich amounts as well. AEW - I'm not convinced that this paper is relevant for full inclusion. Should maybe be referenced but there are earlier examples of the use of chiral Bronsted acids...important to note that its not phosphoric acids as stated above but Binapthyl derived acids. Also, nothing strange about the nucleophilic promoter this is a requirement in M-B-H reactions - most frequently DABCO but can also be a phosphine (as in this case).
  • ILT - June 27 2016 - Botta, 2016 10.2174/1381612822666151231100247 - Recent review of Pictet-Spengler reaction. Difficult to find paper so I put the pdf in the Dropbox 'PDFs' folder.

Papers that have not yet been included, but have been referenced by others

These papers need to be checked for relevance. They typically have come from other, relevant papers, but the relevance may not be clear. If they are relevant and need including, move the citation from this section to the "needs to be included" section above. If you wish to then actually include it in the review, write "your initials - doing" next to the paper and start working.

Introduction/Background to the PS Reaction

Early examples: probably rac/achiral

  • Nature: Naoi, M.; Maruyama, W.; Nagy, G. M. Neurotoxicology 2004, 25, 193- 204 (DOI: 10.1016/S0161-813X(03)00099-8) Paper

Some good medicinal chemistry examples of isatin-derived compounds in Franz 2011 and bencivennia 2011.

Check for the importance of the structural motifs constructed with the reaction:

  • Brown, R. T. In Indoles; Saxton, J. E., Ed.; Wiley- Interscience: New York, 1983; Part 4 (The Monoterpenoid Indole Alkaloids)
  • Bentley, K. W. Nat. Prod. Rep. 2004, 21, 395-424 and references therein
  • W. Jiang, J. Guan, M. J. Macielag, S. Zhang, Y. Qiu, P. Kraft, S. (DOI: 10.1021/jm025545d) Paper

Example chiral auxiliary approach: H. Waldmann, G. Schmidt, H. Henke, and M. Burkard, Angew. Chem. Int. Ed Engl., 1995, 34, 2401. as an example of an "easily removable" chiral aux not being too different from a chiral reagent? Referenced by Nakagawa.

Also possibly: Bhattacharjee, T. M. John, D. Haynes-Johnson, S. Lundeen, Z. Sui, J. Med. Chem. 2005, 48, 2126 – 2133 (DOI: 10.1021/jm0401098) Paper

Specifically with respect to carbolines:

  • Kawasaki, T.; Higuchi, K. Nat. Prod. Rep. 2005, 22, 761–793 (DOI: 10.1039/B502162F) Paper
  • Yu, J.; Wang, T.; Liu, X.; Deschamps, J.; Anderson, J. F.; Liao, X.; Cook, J. M. J. Org. Chem. 2003, 68, 7565–7581 (DOI: 10.1021/jo030006h) Paper
  • Liao, X.; Zhou, H.; Yu, J.; Cook, J. M. J. Org. Chem. 2006, 71, 8884–8890 (DOI: 10.1021/jo061652u) Paper
  • Ma, J.; Yin, W.; Zhou, H.; Cook, J. M. Org. Lett. 2007, 9, 3491–3494 (DOI: 10.1021/ol071220l) Paper
  • Herraiz, T. J. Chromatogr. A 2000, 881, 483–499 (DOI: 10.1016/S0021-9673(99)01313-8) Paper
  • Herraiz, T.; Galisteo, J.; Chamorro, C. J. Agric. Food Chem. 2003, 51, 2168–2173. (DOI: 10.1021/jf0210066) Paper Could cite - carbolines show antioxidant activity.

Diastereoselective examples:

Early diastereoselective, to reference: Ungemach, F.; DiPierro, M.; Weber, R.; Cook, J. M. J. Org. Chem. 1981, 46, 164. (DOI: 10.1021/jo00314a035) Paper

Study to reference: Cox, E. D.; Hamaker, L. K.; Li, J.; Yu, P.; Czerwinski, K. M.; Deng, L.; Bennett, D. W.; Cook, J. M. J. Org. Chem. 1997, 62, 44-61 (DOI: 10.1021/jo951170a) Paper.

To Do:

  • Czarnocki, Z.; MacLean, D. B.; Szarek, W. A. Can. J. Chem. 1986, 64, 2205-2210. (DOI: 10.1139/v86-363) Paper
  • Czarnocki, Z.; Suh, D.; MacLean, D. B.; Hultin, P. G.; Szarek, W. A. Can. J. Chem. 1992, 70, 1555-1561. (DOI: 10.1139/v92-191) Paper
  • Czarnocki, Z.; Mieckzkowsi, J. B.; Kiegiel, J.; Arazn ́y, Z. Tetrahyedron: Asymmetry 1995, 6, 2899-2902. (DOI: 10.1016/0957-4166(95)00380-0) Paper


Papers relating to indole chemistry in asymmetric catalysis, cited by Bencivennia 2011:

  • M. Bandini, A. Eicholtzer, Angew. Chem. Int. Ed. 2009, 48, 9608–9644
  • G. Bartoli, G. Bencivenni, R. Dalpozzo, Chem. Soc. Rev. 2010, 39, 4449 – 4465
  • T. B. Poulsen, K. A. Jørgensen, Chem. Rev. 2008, 108, 2903 – 2915
  • E. MarquØs-López, R. P. Herrera, M. Christmann, Nat. Prod. Rep. 2010, 27, 1138 – 1167

Diastereoselective cited by Leighton: C. Bohlmann, R. Bohlmann, E. G. Rivera, C. Vogel, M. D. Manandhar, E. Winterfeldt, Liebigs Ann. Chem. 1985, 1752 R. Amann, D. Spitzner, Angew. Chem. 1991, 103, 1373; Angew. Chem. Int. Ed. Engl. 1991, 30, 1320 D. L. Comins, M. M. Badawi, Tetrahedron Lett. 1991, 32, 2995 H. Wald- mann, G. Schmidt, M. Jansen, J. Geb, Tetrahedron Lett. 1993, 34, 5867 H. Waldmann, G. Schmidt, M. Jansen, J. Geb, Tetrahedron 1994, 50, 11865 H. Waldmann, G. Schmidt, H. Henke, M. Burkard, Angew. Chem. 1995, 107, 2608; Angew. Chem. Int. Ed. Engl. 1995, 34, 2402 T. Soe, T. Kawate, N. Fukui, T. Hino, M. Nakagawa, Heterocycles 1996, 42, 347 T. Kawate, M. Yamanaka, M. Nakagawa, Heterocycles 1999, 50, 1033

Diastereoelective Reactions

First examples?

  • Ungemach, F.; Soerens, D.; Weber, R.; DiPierro, M.; Campos ;Mokry, P.; Cook, J. M.; Silverton, J. V. J. Am. Chem. Soc. 1980,102,6976.

Diastereoselective (note: must be catalytic for full inclusion - may be no examples):

  • Czarnocki, Z.; MacLean, D. B.; Szarek, W. A. Can. J. Chem. 1986, 64, 2205-2210. (DOI: 10.1139/v86-363) Paper
  • Czarnocki, Z.; Suh, D.; MacLean, D. B.; Hultin, P. G.; Szarek, W. A. Can. J. Chem. 1992, 70, 1555-1561. (DOI: 10.1139/v92-191) Paper
  • Czarnocki, Z.; Mieckzkowsi, J. B.; Kiegiel, J.; Arazn ́y, Z. Tetrahyedron: Asymmetry 1995, 6, 2899-2902. (DOI: 10.1016/0957-4166(95)00380-0) Paper

Lewis Acids

This section is done

Bronsted Acid Section

Akiyama (2004) says these earlier reports "claim" the use of chiral B acids - is that the case, and is the work relevant here?

  • KAB: Not relevant. Not chiral acid, use of chiral aux. in Diels-Alder. C. Palomo, M. Oiarbide, J. M. Garcia, A. Gonzalez, A. Lecumberri, A. Linden, J. Am. Chem. Soc. 2002, 124, 10288 (DOI: 10.1021/ja025906e) Paper
  • KAB: relevant. Early use of chiral phosphoric acids (binol and H8-binol) in enantioselective Morita-Baylis-Hillman reaction. N. T. McDougal, S. E. Schaus, J. Am. Chem. Soc. 2003, 125, 12094 (DOI: 10.1021/ja037705w) Paper MHT - that sounds very relevant - a year before Akiyama/Terada. Needs to be properly included? KAB Jan23 - Probably. It's a bit different to the rest. Acids were catalytic, but also required a "nucleophilic promotor." Not sure what that is, but it was present in less than stoich amounts as well.
  • KAB: not quite relevant. Uses H-bond activation via chiral TADDOL, in highly enantioselective Hetero-Diels-Alder. Y. Huang, A. K. Unni, A. N. Thadani, V. H. Rawal, Nature 2003, 424, 146. MHT - sure, but why is this paper in Nature? What is it showing that is so important, and does this need to be mentioned in the mech section?

Akiyama (2004) also mentions these "metal salt" versions:

  • J. Inanaga, Y. Sugimoto, T. Hanamoto, New J. Chem. 1995, 19, 707 (KAB: Can't access on usyd subscription)
  • KAB: Hetero-DA asymmetric amplification by chiral Yb complexes. H. Furuno, T. Hanamoto, Y. Sugimoto, J. Inanaga, Org. Lett. 2000, 2, 49 (DOI: 10.1021/ol991189q) Paper

Previous Bronsted acid example from Terada

  • KAB: Not relevent. Chiral TADDOL used in hetero-DA reaction - Huang, Y.; Unni, A. K.; Thadani, A. N.; Rawal, V. H. Nature 2003, 424, 146.
  • KAB: See above - McDougal, N. T.; Schaus, S. E. J. Am. Chem. Soc. 2003,125, 12094.

Example of chiral charged Brønsted acid catalyst:

  • Nugent, B. M.; Yoder, R. A.; Johnston, J. N. J. Am. Chem. Soc. 2004,126, 3418.

Jacobsen Strecker and Mannich history, from Terada

  • Sigman, M. S.; Jacobsen, E. N. J. Am. Chem. Soc. 1998, 120, 4901.
  • Vachal, P.; Jacobsen, E. N. Org. Lett. 2000, 2, 867.
  • Sigman, M. S.; Vachal, P.; Jacobsen, E. N. Angew. Chem., Int. Ed. 2000, 39, 1279.
  • Su, J. T.; Vachal, P.; Jacobsen, E. N. AdV. Synth. Catal. 2001, 343, 197.
  • Vachal, P.; Jacobsen, E. N. J. Am. Chem. Soc. 2002, 124, 10013.
  • Wenzel, A. G.; Lalonde, M. P.; Jacobsen, E. N. Synlett 2003, 1919.
  • Wenzel, A. G.; Jacobsen, E. N. J. Am. Chem. Soc. 2002, 124, 12964.

See also:

  • Okino, T.; Hoashi, Y.; Takemoto, Y. J. Am. Chem. Soc. 2003, 125, 12672.
  • Okino, T.; Nakamura, S.; Furukawa, T.; Takemoto,Y. Org. Lett. 2004, 6, 625.

Copper complex example from Terada:

  • Marigo, M.; Kjærsgaard, A.; Juhl, K.; Gathergood, N.; Jørgensen, K. A. Chem.- Eur. J. 2003, 9, 2359.

The strengths of these chiral phosphoric acids is governed by:

Reviews to check through for comments on mechanism of reactions and possible applications of Bronsted acids that have not yet been applied to the PS.

  • S.J. Connon, Angew. Chem. Int. Ed. 2006, 45, 3909–3912
  • T. Akiyama, J. Itoh, K. Fuchibe, Adv. Synth. Catal. 2006, 348, 999 – 1010
  • M. S. Taylor, E. N. Jacobsen, Angew. Chem. Int. Ed. 2006, 45, 1520–1543
  • Connon, S. J. Org. Biomol. Chem. 2007, 5, 3407–3417
  • Terada Synthesis 2010, 1929-1982
  • List, Top. Curr. Chem. 2010, 291, 395-456
  • Rueping Angewandte 2011, 50, 6706-6720
  • S.-L. You, Q. Cai, M. Zeng, Chem. Soc. Rev. 2009, 38, 2190 – 2201
  • A. Zamfir, S. Schenker, M. Freund, S. B. Tsogoeva, Org. Biomol. Chem. 2010, 8, 5262 – 5276 (DOI: 10.1039/c0ob00209g)

Bronsted Acids: N-triflyl phosphoramide Yamamoto 2006, N-triflyl phosphoramide [10.1002/anie.200802139 Rueping 2008] , ? Rueping 2010
Diastereoselective polycyclization involving unactivated Ph using SnCl4 Yamamoto 2006 - suggestion here to use this enantioselectively.

Link from PS page - MNR

Nakamura 2009 - but Aza-Friedel-Crafts Alkylation of Pyrroles
Possible alternative thiophosphoramide: Yamamoto 2008

  • Asymmetric Bronsted Acid Catalyzed Nucleophilic Addition to in situ Generated Chiral N-Acyliminium Ions, Rueping, M.; Nachtsheim, B. J. Synlett 2010, 1, 119. (DOI: 10.1055/s-0029-1218539) - KAB: Probably needs to go in the B acid section.

Organocatalysis Section

This section is done.

Mechanism section

Some possibly relevant papers arising from Dixon 2010, on chiral counterion-induced enantioselective N-acyliminium ion reactions:

  • Li, G.; Kaplan, M. J.; Wojtas, L.; Antilla, J. C. Org. Lett. 2010, 12, 1960.
  • Terada, M.; Machioka, K.; Sorimachi, K. Angew. Chem., Int. Ed. 2009, 48, 2553.
  • Rueping, M.; Lin, M.-Y. Chem.sEur. J. 2010, 16, 4169.

Some papers on dual catalysis referenced by Franz 2011:

  • Yamamoto, H.; Futatsugi, K. Angew. Chem., Int. Ed. 2005, 44, 1924–1942
  • Lv, J.; Li, X.; Zhong, L.; Luo, S.; Cheng, J.-P. Org. Lett. 2010, 12, 1096–1099
  • Rueping, M.; Koenigs, R. M.; Atodiresei, I. Chem. Eur. J. 2010, 16, 9350–9365.

The general reviews need to be checked, to ensure we have not missed anything, and as inspiration for thoughts on the reaction mechanism. e.g. Govindra Org Reactions review we've already cited.

Enzymatic Section

Abe, 2015 (10.1016/j.chembiol.2015.06.006) - Already included, however did not cover stereoselectivity of McbB.

Papers that may need to be included under Expanding our Knowledge of the Pictet-Spenglerase Family subsection under Enzymatic Catalysis:

Monoamine Oxidase (MAO-N)'
Nonribosomal polypeptide synthetase, SfmC
(R)-Salsolinol synthase in human and rat brains
Human morphine biosynthesis